EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer - Archive ouverte HAL
Conference Papers Year : 2017

EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer

Domains

Life Sciences [q-bio] Cancer

David Pasquier  : Connect in order to contact the contributor

https://hal.science/hal-01683897

Submitted on : Sunday, January 14, 2018-10:58:10 PM

Last modification on : Tuesday, June 4, 2024-12:24:03 PM

Consult the full text

Dates and versions

hal-01683897 , version 1 (14-01-2018)

Identifiers

Cite

David Pasquier, A. Hadj Henni, E. Tresch, N. Reynaert, E. Lartigau, et al.. EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer. ESTRO 36 2017 : European Society for Radiotherapy and Oncology, May 2017, Vienna, France. pp.S926 - S927, ⟨10.1016/S0167-8140(17)32226-0⟩. ⟨hal-01683897⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS CRISTAL CRISTAL-MOCIS UNIV-LILLE ONCO-THAI
281 View
0 Download

Altmetric

Share

More